NAKANO Shuji

J-GLOBAL         Last updated: Mar 30, 2019 at 15:58
 
Avatar
Name
NAKANO Shuji
Affiliation
Nakamura Gakuen University
Section
Faculty of Nutritional Sciences, Department of Nutritional Sciences
Degree
Ph.D.(Kyushu University)

Research Areas

 
 

Academic & Professional Experience

 
 
   
 
Professor, Nakamura Gakuen University Graduate School of Health and Nutritional Sciences
 

Education

 
Aug 1978
 - 
Aug 1982
The Jons Hopkins University
 
 
 - 
1974
Faculty of Medicine, Kyushu University
 

Published Papers

 
Otsuka Y, Ueda M, Nakazono E, Tsuda T, Jin X, Noguchi K, Sata S, Miyazaki H, Abe S, Imai K, Iwamoto M, Masuda T, Moriguchi R, Nakano S, Tsuda H
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis   29(1) 39-47   Jan 2018   [Refereed]
Wakimoto R, Ono M, Takeshima M, Higuchi T, Nakano S
Anticancer research   37(11) 6153-6159   Nov 2017   [Refereed]
Ono M, Ejima K, Higuchi T, Takeshima M, Wakimoto R, Nakano S
Nutrition and cancer   69(8) 1300-1307   Nov 2017   [Refereed]
Yasutake K, Moriguchi R, Kajiyama T, Miyazaki H, Abe S, Masuda T, Imai K, Iwamoto M, Tsuda H, Obe M, Kawate H, Ueno H, Ono M, Goromaru R, Ohe K, Enjoji M, Tsuchihashi T, Nakano S
Journal of clinical hypertension (Greenwich, Conn.)   19(7) 653-660   Jul 2017   [Refereed]
Ono M, Takeshima M, Nakano S
The Enzymes   37 139-166   2015   [Refereed]
Antiproliferative and apoptosis-inducing activity of nobiletin against three subtypes of human breast cancer cell lines.
Chen C, Ono M, Takeshima M, Nakano S
Anticancer research   34 1785-1792   Apr 2014   [Refereed]
Takeshima M, Ono M, Higuchi T, Chen C, Hara T, Nakano S
Cancer science   105 252-257   Mar 2014   [Refereed]
Ono M, Higuchi T, Takeshima M, Chen C, Nakano S
Biochemical and biophysical research communications   436 186-191   Jun 2013   [Refereed]
Antiproliferative and apoptosis-inducing activity of curcumin against human gallbladder adenocarcinoma cells.
Ono M, Higuchi T, Takeshima M, Chen C, Nakano S
Anticancer research   33 1861-1866   May 2013   [Refereed]
[Development trends for therapeutic antibody].
Baba E, Kusaba H, Nakano S
Nihon rinsho. Japanese journal of clinical medicine   70 2098-2103   Dec 2012   [Refereed]
Baba E, Fujishima H, Makiyama A, Uchino K, Tanaka R, Esaki T, Kusaba H, Mitsugi K, Nakano S, Akashi K
Advances in therapy   29 287-296   Mar 2012   [Refereed]
Ono M, Koga T, Ueo H, Nakano S
Nutrition and cancer   64 1204-1210   2012   [Refereed]
Baba E, Esaki T, Ariyama H, Mitsugi K, Morikita T, Fujishima H, Kusaba H, Nakano S, Akashi K
Cancer chemotherapy and pharmacology   68 611-617   Sep 2011   [Refereed]
Kusaba H, Esaki T, Futami K, Tanaka S, Fujishima H, Mitsugi K, Sakai K, Ariyama H, Tanaka R, Kinugawa N, Ueki T, Mibu R, Baba E, Nakano S, Akashi K
Cancer science   101 2591-2595   Dec 2010   [Refereed]
Shibata Y, Baba E, Ariyama H, Arita S, Isobe T, Kusaba H, Mitsugi K, Nakano S, Akashi K
Oncology letters   1 423-426   May 2010   [Refereed]
Shibata Y, Ariyama H, Baba E, Takii Y, Esaki T, Mitsugi K, Tsuchiya T, Kusaba H, Akashi K, Nakano S
International journal of clinical oncology   14 397-401   Oct 2009   [Refereed]
Abe Y, Ito T, Baba E, Nagafuji K, Kawabe K, Choi I, Arita Y, Miyamoto T, Teshima T, Nakano S, Harada M
Pancreas   38 815-819   Oct 2009   [Refereed]
Phase I study of the sequential administration of S-1 and cisplatin for metastatic gastric cancer.
Baba E, Fujishima H, Kusaba H, Esaki T, Ariyama H, Kato K, Tanaka R, Mitsugi K, Shibata Y, Harada M, Nakano S
Anticancer research   29 1727-1732   May 2009   [Refereed]
Makiyama A, Qin B, Uchino K, Shibata Y, Arita S, Isobe T, Hirano G, Kusaba H, Baba E, Akashi K, Nakano S
Anti-cancer drugs   20 123-130   Feb 2009   [Refereed]
Moriyama K, Ando C, Tashiro K, Kuhara S, Okamura S, Nakano S, Takagi Y, Miki T, Nakashima Y, Hirakawa H
Microbiology and immunology   52 375-382   Jul 2008   [Refereed]
Arita S, Baba E, Shibata Y, Niiro H, Shimoda S, Isobe T, Kusaba H, Nakano S, Harada M
European journal of immunology   38 1423-1434   May 2008   [Refereed]
Kusaba H, Fujihara M, Nagashima R, Kaji Y, Baba E, Nakano S
Medical oncology (Northwood, London, England)   25 241-244   2008   [Refereed]
Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin.
Shibata Y, Baba E, Ariyama H, Miki R, Ogami N, Arita S, Qin B, Kusaba H, Mitsugi K, Noshiro H, Yao T, Nakano S
World journal of gastroenterology : WJG   13 3634-3637   Jul 2007   [Refereed]
Kusaba H, Shibata Y, Arita S, Ariyama H, Baba E, Mitsugi K, Harada M, Nakano S
Medical oncology (Northwood, London, England)   24 259-264   2007   [Refereed]
Qin B, Ariyama H, Baba E, Tanaka R, Kusaba H, Harada M, Nakano S
Cancer chemotherapy and pharmacology   58 577-584   Nov 2006   [Refereed]
Qin B, Tanaka R, Shibata Y, Arita S, Ariyama H, Kusaba H, Baba E, Harada M, Nakano S
Anti-cancer drugs   17 445-453   Apr 2006   [Refereed]
Qin B, Tanaka R, Ariyama H, Shibata Y, Arita S, Kusaba H, Baba E, Harada M, Nakano S
Anti-cancer drugs   17 439-443   Apr 2006   [Refereed]
Ariyama H, Qin B, Baba E, Tanaka R, Mitsugi K, Harada M, Nakano S
Journal of cellular biochemistry   97 724-734   Mar 2006   [Refereed]
Qin B, Kato K, Mitsugi K, Nakamura M, Tanaka R, Baba E, Ariyama H, Kuroiwa T, Harada M, Nakano S
Cancer chemotherapy and pharmacology   57 114-119   Jan 2006   [Refereed]
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer
Brit. J. Cancer   94 1803-1808   2006   [Refereed]
Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, Nakano N, Ikeda Y, Sasaki T, Nishioka K, Hara M, Taguchi H, Kimura Y, Kato Y, Asaoku H, Kumagai S, Kodama F, Nakahara H, Hagihara K, Yoshizaki K, Kishimoto T
Blood   106 2627-2632   Oct 2005   [Refereed]
Synergistic interaction between oxaliplatin and SN-38 in human gastric cancer cell lines in vitro.
Tanaka R, Ariyama H, Qin B, Shibata Y, Takii Y, Kusaba H, Baba E, Mitsugi K, Harada M, Nakano S
Oncology reports   14 683-688   Sep 2005   [Refereed]
Tanaka R, Takii Y, Shibata Y, Ariyama H, Qin B, Baba E, Kusaba H, Mitsugi K, Harada M, Nakano S
Cancer chemotherapy and pharmacology   56 279-285   Sep 2005   [Refereed]
Numata A, Yasuda K, Fukuda T, Baba E, Yamasaki S, Takase K, Miyamoto T, Nagafuji K, Nakano S, Harada M
The lancet oncology   6 626-628   Aug 2005   [Refereed]
Tanaka R, Ariyama H, Qin B, Takii Y, Baba E, Mitsugi K, Harada M, Nakano S
Cancer chemotherapy and pharmacology   55 595-601   Jun 2005   [Refereed]
外来治療によりCPT-11/5-FU/l-LV (IFL)療法が有効であった肝・肺転移を伴う大腸癌の一例
癌と化学療法   32(9) 1339-1342   2005   [Refereed]
Protection against methotrexate toxicity by a soybean protein- and omega-3 fatty acid-containing diet: comparative study with a casein-containing diet.
Mitsugi K, Nakamura T, Kashiwabara N, Ariyama H, Tanaka R, Baba E, Nakamura M, Harada M, Nakano S
Oncology reports   12 41-45   Jul 2004   [Refereed]
Fujishima H, Kikuchi I, Miyanaga O, Ueda A, Baba E, Mitsugi K, Harada M, Nakano S
International journal of clinical oncology   9 92-97   Apr 2004   [Refereed]
Moriyama K, Hayashida K, Shimada M, Nakano S, Nakashima Y, Fukumaki Y
The Journal of general virology   84 1907-1913   Jul 2003   [Refereed]
Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells.
Boudny V, Nakano S
Anticancer research   23 7-12   Jan 2003   [Refereed]
Hisano C, Tanaka R, Fujishima H, Ariyama H, Tsuchiya T, Tatsumoto T, Mitsugi K, Nakamura M, Nakano S
Cell biology international   27 415-421   2003   [Refereed]
Boudny V, Nakano S
British journal of cancer   86 463-469   Feb 2002   [Refereed]
新規癌遺伝子ect2のヒト癌における遺伝子変異の同定とその治療応用に関する研究
逓信医学   54 351-353   2002   [Refereed]
Defect of lck in a patient with common variable immunodeficiency
Int. J. Molecular Medicine   7 609-614   2001   [Refereed]
[A case of metastatic colon carcinoma in which a continuous intrahepatic artery-infusion of 5-FU leucovorin and cisplatin, and systemic chemotherapy with CPT-11 was very effective].
Ishikawa T, Nakamura M, Ohkuma K, Hisano C, Nakano S, Maruyama T, Kaji Y, Niho Y, Masumoto N
Gan to kagaku ryoho. Cancer & chemotherapy   27 1443-1447   Aug 2000   [Refereed]
Tokumitsu Y, Nakano S, Ueno H, Niho Y
Journal of cellular physiology   183 221-227   May 2000   [Refereed]
Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group.
Koizumi W, Kurihara M, Nakano S, Hasegawa K
Oncology   58 191-197   Apr 2000   [Refereed]
[Molecular targeting as a new strategy for cancer chemotherapy].
Nakano S
Fukuoka igaku zasshi = Hukuoka acta medica   91 1-7   Jan 2000   [Refereed]
5-FU, LV, CDDPの肝動脈持続動注とCTP-11の全身投与療法が著効した大腸癌肝転移の1例
癌と化学療法   27(9) 1443-1447   2000   [Refereed]
Expression of activated c-erbB-2 oncogene induces sensitivity to cisplatin in human gallbladder adenocarcinoma cells.
Boudny V, Murakami Y, Nakano S, Niho Y
Anticancer research   19 5203-5206   Nov 1999   [Refereed]
Masumoto N, Nakano S, Fujishima H, Kohno K, Niho Y
International journal of cancer. Journal international du cancer   80 731-737   Mar 1999   [Refereed]
Nakano S
Internal medicine (Tokyo, Japan)   38 186-190   Feb 1999   [Refereed]
Okuma K, Nakamura M, Nakano S, Tanaka Y, Niho Y
Archives of virology   144 1-18   1999   [Refereed]
Prognostic significance of polo-like kinase in esophageal carcinoma
International J. Oncology   15 687-692   1999   [Refereed]
[Current status of cancer management. 3. New molecular targets in cancer chemotherapy].
Nakano S
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine   87 1763-1767   Sep 1998   [Refereed]
Murakami Y, Nakano S, Niho Y, Hamasaki N, Izuhara K
Journal of cellular physiology   175 220-228   May 1998   [Refereed]
Fujishima H, Nakano S, Tatsumoto T, Masumoto N, Niho Y
International journal of cancer. Journal international du cancer   76 423-429   May 1998   [Refereed]
Molecular and genetic analysis of two patients with Bernard-Soulier syndrome--identification of new mutations in glycoprotein Ib alpha gene.
Kanaji T, Okamura T, Kurolwa M, Noda M, Fujimura K, Kuramoto A, Sano M, Nakano S, Niho Y
Thrombosis and haemostasis   77 1055-1061   Jun 1997   [Refereed]
Hepatitis GB virus C genome in the serum of aplastic anaemia patients receiving frequent blood transfusions.
Moriyama K, Okamura T, Nakano S
British journal of haematology   96 864-867   Mar 1997   [Refereed]
[Cell signaling and CDDP resistance].
Masumoto N, Nakano S
Gan to kagaku ryoho. Cancer & chemotherapy   24 424-430   Feb 1997   [Refereed]
[A case of colon cancer with local recurrence successfully treated by systemic and local intra-arterial chemotherapy using a combination of 5-fluorouracil, interferon-alpha 2A, leucovorin and carboplatin].
Takasaki S, Masumoto N, Tabata H, Nakamura M, Nakano S, Niho Y
Gan to kagaku ryoho. Cancer & chemotherapy   24 109-113   Jan 1997   [Refereed]
Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
Fujishima H, Nakano S, Masumoto N, Esaki T, Tatsumoto T, Kondo T, Niho Y
Oncology research   9 167-172   1997   [Refereed]
5-fluorouracil, Interferon alpha 2a, leucovorin, carboplatinを使用した全身および局所動注化学療法が奏効した再発大腸癌の一例
癌と化学療法   24(1) 109-113   1997   [Refereed]
Fukazawa H, Nakano S, Mizuno S, Uehara Y
International journal of cancer. Journal international du cancer   67 876-882   Sep 1996   [Refereed]
[Comparative trial of granisetron alone and granisetron plus methylprednisolone for prevention of nausea and vomiting during cancer chemotherapy].
Hisano C, Nakano S, Okuma K, Masumoto N, Fujishima H, Nakamura M, Niho Y
Gan to kagaku ryoho. Cancer & chemotherapy   23 1175-1181   Aug 1996   [Refereed]
Esaki T, Nakano S, Masumoto N, Fujishima H, Niho Y
International journal of cancer. Journal international du cancer   65 479-484   Feb 1996   [Refereed]
発症後3ヶ月の経過で死亡した膵癌症例 ーターミナルケア実践例
内科専門医会誌   8(3) 262-265   1996   [Refereed]
クロスオーバー法による癌化学療法時のGranisetron単独とMethyl-PSL併用療法の制吐効果の検討
癌と化学療法   23 1175-1181   1996   [Refereed]
Masumoto N, Nakano S, Esaki T, Fujishima H, Tatsumoto T, Niho Y
International journal of cancer. Journal international du cancer   62 70-75   Jul 1995   [Refereed]
[A cooperative late phase II trial of l-leucovorin and 5-fluorouracil in the treatment of advanced gastric cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
Takeda S, Taguchi T, Ohta J, Kurihara M, Abe T, Ohtani T, Yonemura Y, Ohno T, Hirabayashi N, Nakano S
Gan to kagaku ryoho. Cancer & chemotherapy   22 903-910   Jun 1995   [Refereed]
Tatsumoto T, Nakano S, Shimizu K, Ono M, Esaki T, Ohshima K, Niho Y
International journal of cancer. Journal international du cancer   61 206-213   Apr 1995   [Refereed]
A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E, Nakamura M, Ohkuma K, Kira J, Tanaka Y, Nakano S, Niho Y
Journal of immunology (Baltimore, Md. : 1950)   154 399-412   Jan 1995   [Refereed]
Sequence-dependent modulation of anticancer drug activities by 7-ethyl-10-hydroxycamptothecin in an HST-1 human squamous carcer cell line
Anticancer Res.   15 405-410   1995   [Refereed]
他施設共同研究によるl-LV・5-FU併用療法の進行結腸・直腸癌に対する後期第II相試験
癌と化学療法   22 925-931   1995   [Refereed]
他施設共同研究によるl-leucovorin・5-FU併用療法の進行胃癌に対する後期第II相試験
癌と化学療法   22 903-910   1995   [Refereed]
Characterization of a newly established human gallbladder carcinoma cell line.
Nakano S, Tatsumoto T, Esaki T, Nakamura M, Baba E, Kimura A, Ohshima K, Niho Y
In vitro cellular & developmental biology. Animal   30A 729-732   Nov 1994   [Refereed]
Nakano S, Niho Y
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine   83 1538-1542   Sep 1994   [Refereed]
[A case of advanced gastric cancer complicated with multiple liver metastasis successfully treated with l-LV and 5-FU combination].
Fujishima H, Mitsugi K, Nakamura M, Yoshimatsu H, Nakano S, Niho Y
Gan to kagaku ryoho. Cancer & chemotherapy   21 869-872   May 1994   [Refereed]
l-Leucovorin・5-FU併用療法が奏効した肝転移合併進行胃癌の一例
癌と化学療法   21(6) 869-872   1994   [Refereed]
[Successful treatment of recurrent multiple lung metastasis from colon cancer with combination chemotherapy using methotrexate, 5-fluorouracil, and high-dose leucovorin: a case report].
Mitsugi K, Yasutake T, Etoh T, Ishimaru T, Ueda A, Nakano S, Niho Y
Gan to kagaku ryoho. Cancer & chemotherapy   20 2387-2390   Dec 1993   [Refereed]
[A case of pulmonary metastasis from colon cancer successfully treated by 5-FU combined with leucovorin and interferon alpha-2a].
Ichiki Y, Nakano S, Hirata Y, Nakamura M, Kanaya S, Niho Y
Gan to kagaku ryoho. Cancer & chemotherapy   20 2239-2242   Nov 1993   [Refereed]
Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E, Nakamura M, Tanaka Y, Kuroki M, Itoyama Y, Nakano S, Niho Y
Journal of immunology (Baltimore, Md. : 1950)   151 1013-1024   Jul 1993   [Refereed]
Growth modulation of human tumor cells by a growth-inhibiting activity derived from tumorigenic V79 Chinese hamster cells.
Ichinose I, Nakano S, Esaki T, Koga T, Mitsugi K, Yamada H, Niho Y
In vitro cellular & developmental biology. Animal   29A 332-338   Apr 1993   [Refereed]
[5-fluorouracil + low-dose leucovorin and cisplatin sequential chemotherapy with dipyridamole for advanced nonresectable squamous cell carcinoma of the lung: a case report].
Sugimori H, Nakano S, Chifu Y, Mitsugi K, Kudo J, Ishida T, Niho Y
Gan to kagaku ryoho. Cancer & chemotherapy   20 287-290   Feb 1993   [Refereed]
Sarcoid reactions in regional lymph nodes of primary lung cancer.
Sugio K, Inoue T, Yokoyama H, Ishida T, Nakano S, Sugimachi K
Respiration; international review of thoracic diseases   60 133-136   1993   [Refereed]
5-FU + Low dose LV + Cisplatin時間差化学療法にDipyridamoleを併用し,著効を示した非切除進行肺扁平上皮癌の一例
癌と化学療法   20(2) 287-290   1993   [Refereed]
5-FU/Leucovorin/IFN α-2a併用療法が奏効した大腸癌の肺転移の一例
癌と化学療法   20(14) 2239-2242   1993   [Refereed]
再発大腸癌肺転移巣に対しMTX併用 5-FU・大量Leucovorin持続静注が奏効した一例
癌と化学療法   20(15) 2387-2390   1993   [Refereed]
Production of anti-cardiolipin antibody in AKR/J mice with STZ-induced insulitis and diabetes
Diabetes Res. Clin. Practice   20 29-37   1993   [Refereed]
Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
Esaki T, Nakano S, Tatsumoto T, Kuroki-Migita M, Mitsugi K, Nakamura M, Niho Y
Cancer research   52 6501-6506   Dec 1992   [Refereed]
Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
Kuroki M, Nakamura M, Itoyama Y, Tanaka Y, Shiraki H, Baba E, Esaki T, Tatsumoto T, Nagafuchi S, Nakano S
Journal of immunology (Baltimore, Md. : 1950)   149 940-948   Aug 1992   [Refereed]
Increase of peripheral B lymphocytes committed to the production of monoreactive and high affinity antibodies to HTLV-1 in patients with HAM/TSP.
Nakamura M, Itoyama Y, Kuroki M, Nakano S, Kondoh S, Nagafuchi S, Kira J, Ichinose I, Mitsugi K, Anzai K
Journal of neuroimmunology   37 35-45   Mar 1992   [Refereed]
Kuroki M, Nakano S, Mitsugi K, Ichinose I, Anzai K, Nakamura M, Nagafuchi S, Niho Y
Cancer chemotherapy and pharmacology   29 273-276   1992   [Refereed]
Simple and efficient chemosensitivity assay for human primary tumor cells using contact-sensitive microtiter plate
International. J. Oncology   1 141-147   1992   [Refereed]

Misc

 
竹嶋美夏子, 原孝之, 中野修治
日本栄養・食糧学会大会講演要旨集   67th 140   Apr 2013
小野美咲, 中野修治
月刊臨床と研究   89(12) 1712-1718   Dec 2012
馬場英司, 草場仁志, 中野修治
日本臨床   70(12) 2098-2103   Dec 2012
竹嶋美夏子, 原孝之, 中野修治
日本農芸化学会西日本支部大会およびシンポジウム講演要旨集   2012 54   Sep 2012
植田麻衣子, 中園栄里, 津田友秀, 金秀日, 中野修治, 津田博子
日本老年医学会雑誌   49(5) 667   Sep 2012
小野美咲, 竹嶋美夏子, 中野修治
栄養学雑誌   70(5 Supplement) 382   Sep 2012
竹嶋美夏子, 小野美咲, 中野修治
栄養学雑誌   70(5 Supplement) 309   Sep 2012
森口里利子, 伊藤和枝, 高妻和哉, 落合龍史, 中野修治
日本栄養・食糧学会大会講演要旨集   66th 153   Apr 2012
竹嶋美夏子, 原孝之, 中野修治
日本栄養・食糧学会大会講演要旨集   66th 161   Apr 2012
植田麻衣子, 中園栄里, 中園栄里, 津田友秀, 金秀日, 中野修治, 中野修治, 津田博子, 津田博子
日本血栓止血学会誌   23(2) 167   Apr 2012
辰市舞, 中野修治, 中川緑
日本薬学会年会要旨集   132nd(4) 284   Mar 2012
中園栄里, 中園栄里, 今井克己, 今井克己, 阿部志麿子, 岩本昌子, 岩本昌子, 森口里利子, 宮崎瞳, 小野美咲, 小野美咲, 八住香代子, 上野宏美, 森山耕成, 森山耕成, 中野修治, 中野修治, 津田博子, 津田博子
Osteoporosis Jpn   19 278   Nov 2011
上野宏美, 宮崎瞳, 今井克己, 近江雅代, 大部正代, 岩本昌子, 大和孝子, 森口里利子, 竹嶋美夏子, 相島英津子, 小野美咲, 中野修治
栄養学雑誌   69(5 Supplement) 246   Sep 2011
志岐歩美, 北原勉, 吉村嘉代, 深野陽子, 渡辺啓子, 中野修治, 中野修治, 森山耕成, 森山耕成
栄養学雑誌   69(5 Supplement) 203   Sep 2011
八住香代子, 八木香里, 岩本昌子, 岩本昌子, 今井克己, 今井克己, 阿部志麿子, 森口里利子, 津田博子, 津田博子, 中園栄里, 中園栄里, 宮崎瞳, 小野美咲, 小野美咲, 上野宏美, 森山耕成, 森山耕成, 中野修治, 中野修治
栄養学雑誌   69(5 Supplement) 317   Sep 2011
小野美咲, 相島英津子, 中野修治
栄養学雑誌   69(5 Supplement) 210   Sep 2011
岩本昌子, 本間学, 八住香代子, 志岐歩美, 中野修治, 吉岡慶子, 森山耕成
栄養学雑誌   69(5 Supplement) 179   Sep 2011
宮崎瞳, 上野宏美, 今井克己, 阿部志麿子, 増田隆, 森口里利子, 津田博子, 岩本昌子, 中園栄里, 小野美咲, 林梨恵, 八住香代子, 森山耕成, 大部正代, 相島英津子, 中野修治
日本栄養・食糧学会大会講演要旨集   65th 112   Apr 2011
The Clinical Guide to Oncology Nutrition, Second Edition
メディカルレビュー社      2011
北原勉, 北原勉, 片渕史佳, 野田典子, 南里幸一郎, 今村徹, 藤永拓朗, 東和也, 梅田征夫, 高柴哲次郎, 佐々木裕光, 中野修治, 森山耕成
月刊臨床と研究   87(10) 1482-1488   Oct 2010
中園栄里, 中園栄里, 津田博子, 津田博子, 今井克己, 今井克己, 阿部志磨子, 森口里利子, 岩本昌子, 岩本昌子, 宮崎瞳, 小野美咲, 八住香代子, 林梨恵, 上野宏美, 森山耕成, 森山耕成, 中野修治, 中野修治
栄養学雑誌   68(5 Supplement) 340   Sep 2010
八住香代子, 岩本昌子, 今井克己, 阿部志麿子, 森口里利子, 津田博子, 中園栄里, 宮崎瞳, 小野美咲, 林梨恵, 上野宏美, 森山耕成, 中野修治
栄養学雑誌   68(5 Supplement) 340   Sep 2010
ABE Yasunobu, ITO Tetsuhide, BABA Eishi, NAGAFUJI Koji, KAWABE Ken, CHOI Ilseung, ARITA Yoshiyuki, MIYAMOTO Toshihiro, TESHIMA Takanori, NAKANO Shuji, HARADA Mine
25(1) 92-94   Feb 2010
藤本千夏, 牧山明資, 在田修二, 江崎泰斗, 磯部大地, 有山寛, 薦田正人, 白川剛, 内野慶太, 草場仁志, 馬場英司, 赤司浩一, 三ツ月健二, 田中吏佐, 中野修治
日本癌治療学会誌   44(2) 648   Sep 2009
森山耕成, 森山耕成, 木藤弘子, 北原勉, 戸田真理, 永島重喜, 今橋孝治, 中野修治, 今村徹, 佐々木裕光
日本病態栄養学会誌   11(5) 123   Dec 2008
古賀里利子, 津田博子, 中園栄里, 蒲原朋子, 小野美咲, 中野修治, 坂田利家
肥満研究   14(Supplement) 129   Sep 2008
消化器癌の化学療法
今日の治療指針、医学書院 306-308      2008
中野修治
コンセンサス癌治療   6(4) 222-225   Nov 2007
中野修治
日本病態栄養学会誌   10(4) 453   Nov 2007
牧山明資, 内野慶太, 磯部大地, 平野元, 在田修二, 柴田義宏, 草場仁志, 馬場英司, 中野修治
日本癌学会学術総会記事   66th 560   Aug 2007
杉原恵美, 杉原恵美, 森田浩光, 井上良介, 松田美穂, 中野修治, 井上隆司, 伊東祐之, 安部喜八郎, 平田雅人
生化学   2P-0312   2007
OPTIMOX1:進行大腸癌に対するFOLFOX4とオキサリプラチン間欠投与によるFOLFOX7との不作為比較試験
草場仁志、馬場英司、中野修治
The Medical Oncologist   2(7) 43-48   2006
v-Src inhibits detachment-induced apoptosis through constitutive activation of p125FAK in HAG-1 human epithelial cell line
Cell Biol. Int.   27: 415-421    2003
Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells
Anticancer Research   23: 7-12    2003
Detect of lck in a patient with common variable immunodeficiency
Int. J. Molecular Medicine   (7), 609-614    2001
Molecular Target for Hematological Malignancies and Cancer
Kyushu University Press      2000
Phase 2 Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer.
Oncology   58 191-197   2000
Expert’s Comments.TRAILと癌
中野修治
Apoptosis Watch for Cancer Chemotherapy   3(7)    2000
癌の分子標的治療?新しい癌化学療法の戦略
中野修治
福岡医学雑誌   91(1) 1-7   2000
Shuji NAKANO
Internal Medicine   38(2) 186-190   1999
Prognostic significance of polo-like kinase in esophageal carcinoma.
International J. Oncology   15 687-692   1999

Books etc

 
5-FU/Cisplatin Chemotherapy
1995   
Inhibition by 5-fluorouracil of the repair of Cisplatin-induced DNA adducts as a mechanism of the sequence-dependent synergy
Recent Advance in Chemotherapy   1994   

Research Grants & Projects

 
Ministry of Education, Culture, Sports, Science and Technology: Grants-in-Aid for Scientific Research(基盤研究(C))
Project Year: 2008 - 2010    Investigator(s): Shuji NAKANO
Incidence of breast and colon cancer is increasing recently among Japanese women. As these cancers are considered to be obesity- and diet-linked diseases, we have investigated the association of breast carcinogenesis with visceral fat obesity and ...
Ministry of Education, Culture, Sports, Science and Technology: Grants-in-Aid for Scientific Research(基盤研究(C))
Project Year: 2006 - 2007    Investigator(s): Shuji NAKANO
Although gefitinib, a selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, has been clinically demonstrated to be effective for certain cancer cell types, the molecular mechanisms of the anti-tumor activity have not been...
Ministry of Education, Culture, Sports, Science and Technology: Grants-in-Aid for Scientific Research(基盤研究(C))
Project Year: 2002 - 2004    Investigator(s): Shuji NAKANO
Activation of Src and Ras has been demonstrated be closely associated with the pathogenesis and metastatic potential of many human tumors. However, the role of these oncogenes in the drug sensitivity and invasion process remain to be clarified. We...
Ministry of Education, Culture, Sports, Science and Technology: Grants-in-Aid for Scientific Research(基盤研究(C))
Project Year: 2000 - 2001    Investigator(s): Shuji NAKANO
Activation of Src and Ras has been demonstrated be closely associated with the pathogenesis and metastatic potential of many human tumors. However, the role of these oneogenes in the drug sensitivity and invasion process remain to be clarified. We...
Ministry of Education, Culture, Sports, Science and Technology: Grants-in-Aid for Scientific Research(基盤研究(C))
Project Year: 1998 - 1999    Investigator(s): Shuji NAKANO
Although src or ras oncogene induces transformation, their precise roles in the apoptotic machinery and invasion remain to be clarified. We examined the role of these oncogenes on the detachment-induced apoptosis termed anoikis and invasion potent...